Numerous clinical studies have established that angiotensin II receptor blockers are effective as antihypertensive therapy and are well tolerated. Studies demonstrate that adding an angiotensin II ...

Searches of MEDLINE, EMBASE, and BIOSIS databases identified four similarly designed, randomized, factorial studies comparing various doses of angiotensin II receptor blockers with ...

Researchers have developed a cellular fractionation protocol. This method allows for precise analysis of the proteins located ...

The following is a summary of “Association between the use of angiotensin-converting enzyme inhibitors /angiotensin receptor ...

A study by St. Michael’s Hospital suggests that a common type of blood pressure medication, called angiotensin receptor ...

Researchers from the Institute for Neurosciences (IN), a joint center of the Miguel Hernández University of Elche (UMH) and ...

AOP Orphan Pharmaceuticals GmbH (AOP Health), based in Vienna, Austria, announced that the U.S. Food and Drug Administration ...

In a randomized controlled trial of people with type 2 diabetes, albuminuria, and estimated glomerular filtration rate (eGFR) ...

A recent study published in the Lancet Diabetes & Endocrinology journal states that weight loss drugs can lower kidney ...

The findings of this study could open new avenues for Alzheimer's disease treatment. "With this protocol, we can accurately determine whether specific agents, such as modulators or blockers, have a ...

Researchers have discovered that a drug commonly used to treat hypertension can extend lifespan and slow down aging. The ...